Topics

New Study Demonstrates the Ability of Prolaris to Predict which Men with Prostate Cancer will Benefit from Multi-Modality Therapy

10:17 EST 14 Feb 2020 | Speciality Pharma Journal

SALT LAKE CITY, Feb. 14, 2020 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, announced that it is presenting new data at the American Society of Clinical Oncology Genitouranary Cancer Symposium in San Francisco, California. The key finding is that Prolaris accurately predicts which men with intermediate …

Original Article: New Study Demonstrates the Ability of Prolaris to Predict which Men with Prostate Cancer will Benefit from Multi-Modality Therapy

NEXT ARTICLE

More From BioPortfolio on "New Study Demonstrates the Ability of Prolaris to Predict which Men with Prostate Cancer will Benefit from Multi-Modality Therapy"

Quick Search

Relevant Topics

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...